Susquehanna International Group’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-41,400
Closed -$20K 9946
2016
Q1
$20K Buy
+41,400
New +$18.1K ﹤0.01% 8811
2015
Q4
Sell
-13,100
Closed -$17K 10436
2015
Q3
$17K Buy
+13,100
New +$15.3K ﹤0.01% 9516
2015
Q2
Sell
-20,000
Closed -$41K 10737
2015
Q1
$41K Sell
20,000
-173,700
-90% -$357K ﹤0.01% 9187
2014
Q4
$289K Sell
193,700
-1,100
-0.6% -$1.96K ﹤0.01% 8197
2014
Q3
$454K Sell
194,800
-35,200
-15% -$134K ﹤0.01% 7390
2014
Q2
$1.05M Buy
230,000
+100
+0% +$432 ﹤0.01% 5959
2014
Q1
$1.02M Sell
229,900
-10,500
-4% -$53.8K ﹤0.01% 5496
2013
Q4
$1.14M Sell
240,400
-66,800
-22% -$328K ﹤0.01% 5287
2013
Q3
$1.57M Sell
307,200
-83,300
-21% -$392K ﹤0.01% 4513
2013
Q2
$1.7M Buy
+390,500
New +$1.77M ﹤0.01% 4163

Susquehanna International Group's ALXA Position: Q2 2016 in Review

Susquehanna International Group sold out of Alexza Pharmaceuticals Inc (ALXA) in Q2 2016, closing a stake of 26,110 shares — an estimated $13K sold.

Susquehanna International Group first reported a position in ALXA in Q4 2013 and held it in 6 quarters. The position peaked at $115K in Q4 2013. 0 funds tracked by Wall St. Rank hold ALXA as of Q2 2016.

  • Susquehanna International Group reported no remaining Alexza Pharmaceuticals Inc position as of Q2 2016 after selling out during the quarter.
  • Susquehanna International Group sold 26,110 Alexza Pharmaceuticals Inc shares in Q2 2016, an estimated $13K.
  • Susquehanna International Group first reported a position in Alexza Pharmaceuticals Inc in Q4 2013 and held it in 6 quarters.
  • Susquehanna International Group's Alexza Pharmaceuticals Inc position peaked at $115K in Q4 2013.
  • 0 funds tracked by Wall St. Rank held Alexza Pharmaceuticals Inc as of Q2 2016.

Based on Susquehanna International Group's 13F filing for Q2 2016, filed 15 Aug 2016.